Advertisement

Die Mycoplasmen (PPL-Organismen und ihre klinische Bedeutung)

  • Friedrich J. Bassermann

Zusammenfassung

Die Mycoplasmataceen gehören zu den am längsten bekannten Mikroorganismen. Aber erst in den letzten Jahren finden sie aus unterschiedlichen Gründen ein nunmehr rasch wachsendes Interesse, insbesondere auch seitens der Humanmedizin. Seit Ende der zwanziger Jahre hat eine kleine Gruppe von Bakteriologen und Mikrobiologen unsere Kenntnisse über die auch heute noch recht geheimnisvollen und problemreichen Kleinlebewesen schrittweise erweitert. Hierzu sei auf die aus reicher Erfahrung schöpfende Monographie von E. Klieneberger-Nobel (1962) verwiesen [69].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Anderson, D. L.: Electron microscopic observations of the structure of Mycoplasma laidlawii. Electron Microscopic Proc. European regional Conf., 3rd, Prague, 1964, 539–540.Google Scholar
  2. 2.
    Anderson, D. R., and M. F. Barile: Ultrastructure of Mycoplasma hominis. J. Bacteriol. 90, 180–192 (1965).PubMedGoogle Scholar
  3. 3.
    Anderson, D. R., and M. F. Barile: Ultrastructure of Mycoplasma orale isolated from patients with leucaemia. J. Nat. Cancer Inst. 1965, 161–167.Google Scholar
  4. 4.
    Anderson, D. R., H. E. Horns, M. F. Barile, and Barbara C. Bernheim: Comparison of the ultra-structure of several Rickettsiae, Ornithosis virus and Mycoplasma in tissue culture. J. Bacteriol. 90, 1387–1404 (1965).PubMedGoogle Scholar
  5. 5.
    Baernstein, H. D., E. Trevisani, S. Axtell, and J. J. Quilligan, jr.: Mycoplasma pneumoniae (Eaton atypical pneumonia agent) in children’s respiratory infections. J. Pediatrics 66, 829–837 (1965).CrossRefGoogle Scholar
  6. 6.
    Bakos, K., A. Bane und E. Thal: Mycoplasmen (PPLO) in Beziehung zur Fruchtbarkeit bei Bullen. Zbl. Vet. Med. 9, 397–410 (1962).Google Scholar
  7. 7.
    Barile, M. F., G. P. Bodey, J. Snyder, D. B. Riggs, and Marion W. Grabowski: Isolation of Mycoplasma orale from leucaemic bone marrow and blood by direct culture. J. Nat. Cancer Inst. 1966, 155.Google Scholar
  8. 8.
    Barile, M. F., W. F. Malizia, and D. B. Riggs: Immunofluorescence of PPLO in tissue cultures. Bacteriol. Proc. 1961, 83.Google Scholar
  9. 9.
    Barile, M. F., W. F. Malizia, and D. B. Riggs: Incidence and detection of pleuropneumonia-like organisms in cell cultural J. Bacteriol. 84, 130–136 (1962).PubMedGoogle Scholar
  10. 10.
    Barile, M. F., and R. T. Schimre: A rapid chemical method for detecting PPLO contamination of tissue cell cultures. Proc. Soc. exp. Biol. Med. 114, 676–679 (1963).CrossRefGoogle Scholar
  11. 11.
    Barile, M. F., R. T. Schimre, and D. B. Riggs: Presence of the arginine Dihydrolase pathway in Mycoplasma. J. Bacteriol. 91, 189–192 (1966).PubMedGoogle Scholar
  12. 12.
    Bartmann, K., and W. Höpken: Zur Heteromorphie der Bakterien. Bildatlas pathogener Mikroorganismen. G. HENNEBERG. Stuttgart: Gustav Fischer 1963.Google Scholar
  13. 13.
    Bassermann, F. J.: Die L-Form des Tuberkuloseerregers in elektronenoptischer Dar-stellung. Beitr. Klin. Tuberk. 113, 134–145 (1955).CrossRefGoogle Scholar
  14. 14.
    Bassermann, F. J.: Die nachgehende diagnostische Klärung flüchtiger Lungeninfiltrate. Tuberk.-Arzt 16, 424–434 (1962).Google Scholar
  15. 15.
    Bassermann, F. J.: Flüchtige unspezifische Lungeninfiltrate; Viruspneumonien. Beitr. Klin. Tuberk. 132, 165–177 (1965).CrossRefGoogle Scholar
  16. 16.
    Bassermann, F. J.: Vorkommen und Bedeutung von Mycoplasmataceen (PPLO) im menschlichen Atemtrakt. Prax. Pneumol. 20, 317–324 (1966).PubMedGoogle Scholar
  17. 17.
    Bassermann, F. J.: Virogene Infektionen der Atemwege. Dtsch. med. Wschr. 91, 1887–1889 (1966).CrossRefGoogle Scholar
  18. 18.
    Beller, K.: Infektiöse Agalaktie der Ziegen und der Schafe. In: Hdb. d. Viruskrankheiten, 2. Bd. Jena: Gustav Fischer 1939.Google Scholar
  19. 19.
    Breed, R. S., E. G. D. Mur-Ray, and N. R. Smith: Baltimore: The Williams and Wilkins Co. 1957.Google Scholar
  20. 20.
    Bögel, K., M. Berchthold, M. A. Brunner and L. Klinger: Die Eignung der Gewebekulturtechnik zur Isolierung und Charakterisierung eines zytopathogenen Mycoplasmastammes von Bullen. Zbl. Bakteriol. I. Orig. 185, 423–439 (1952).Google Scholar
  21. 21.
    Borgno, M.: Unspezifische Urethriden. Munch. med. Wschr. 107, 2645–2648 (1965).Google Scholar
  22. 22.
    Brenner, S., and R. Horne: A negative staining method for high resolution electron microscopy of viruses. Biochem. Biophys. Acta 34, 103–110 (1959).PubMedCrossRefGoogle Scholar
  23. 23.
    Bridé, J., and A. Donatien: Le microbe de l’agalaxie contagieuse des chèvres et sa culture in vitro. C. r. Acad. Sci. 177, 841 (1923).Google Scholar
  24. 24.
    Bridé, J., and A. Donatien: Le microbe l’agalaxie contagieuse du mouton et de la chèvre. Ann. Inst. Pasteur 39, 925 (1925).Google Scholar
  25. 25.
    Carski, R. C., and CH. C. Shepard: Pleuropneumonia-like (Mycoplasma) infections of tissue culture. J. Bacteriol. 81, 626–635 (1961).PubMedGoogle Scholar
  26. 26.
    Chalquest, R. R.: Cultivation of the infectious synovitis-type pleuropneumonia-like organisms. Avian Dis. 6, 36–43 (1962).CrossRefGoogle Scholar
  27. 27.
    Chalquest, R. R., and J. Fabricant: Pleuropneumonia-like organisms associated with synovitis in fowls. Avian Dis. 4, 515–539 (1960).CrossRefGoogle Scholar
  28. 28.
    Chanock, R. M.: Mycoplasma pneumoniae. Proposed nomenclature for atypical Pneumonia organisms (Eaton agent). Science 140, 662 (1963).PubMedCrossRefGoogle Scholar
  29. 29.
    Chanock, R. M., M. K. Cook, H. H. Fox, R. H. Parrott and R. J. Huebner: Serologic evidence of infection with Eaton agent in lower respiratory illness in childhood. New Engl. J. Med. 262, 648–654 (1960).Google Scholar
  30. 30.
    Chanock, R. M., L. Hayflick, and M. F. Barile: Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO. Proc. Nat. Acad. Sci. 48, 41–49 (1962).PubMedCrossRefGoogle Scholar
  31. 31.
    Chanock, R. M., M. A. Mufson, H. H. Bloom, W. D. James, H. H. Fox, and J. R. Kingston: Eaton agent pneumonia, I. Ecology of infection in an military recruit population. J. Amer. med. Ass. 175, 213–220 (1961).Google Scholar
  32. 32.
    Chanock, R. M., M. A. Mufson, N. L. Somerson, and R. B. Cough: Role of mycoplasma (PPLO) in human respiratory disease. Amer. Rev. resp. Dis. 88, 218 (1962).Google Scholar
  33. 33.
    Chanock, R. M., D. Rifkind, H. M. Kravetz, V. Knight, and K. M. Johnson: Respiratory disease in volunteers infected with Eaton agent. Prod. Nat. Acad. Sci. 47, 887–890 (1961).CrossRefGoogle Scholar
  34. 34.
    Clyde, W. A.: Demonstration of Eaton’s agent in tissue culture. Proc. Soc. exp. Biol. Med. 107, 715–718 (1961).PubMedCrossRefGoogle Scholar
  35. 35.
    Clyde, W. A.: Hemolysis in identifying Eaton’s pleuropneumonialike organisms. Science 139, 55 (1963).PubMedCrossRefGoogle Scholar
  36. 36.
    Clyde, W. A.: Mycoplasma species identification based upon growth inhibition by specific antisera. J. Immunol. 92, 958–965 (1964).PubMedGoogle Scholar
  37. 37.
    Collier, L. H.: Contamination of stock lines of human carcinoma cells by pleuropneumonia-like organisms. Nature 180, 757–758 (1957).PubMedCrossRefGoogle Scholar
  38. 38.
    Cook, M. K., R. M. Chanock, H. H. Fox, E. L. Buescher, R. T. Johnson, and R. J. Huebner: Studies on the role of Eaton agent in lower respiratory tract illness. Evidence for infection in adults. Brit. med. J. 1, 905–911 (1960).Google Scholar
  39. 39.
    Dacie, J. V.: The hemolytic anaemias, 2rd. Ed. New York: Grune and Stratton 1962, p. 342–494.Google Scholar
  40. 40.
    Dannis, C., and J. H. Marston: Fine structure of staphylococcal L-forms. Texas Rep. Biol. Med. 23, 729–736 (1965).Google Scholar
  41. 41.
    Dienes, L.: Electron micrographs made from L-forms of Proteus and two human strains of Pleuropneumonia-like Organisms. J. Bacteriol. 66, 280–283 (1953).PubMedGoogle Scholar
  42. 42.
    Djkman, J. H.: Onderzoek over het voorkomen en de oorzaken van logafurigkingen biy militairen met akute luchtweginfekties. Proefschrift Nijmegen 1963.Google Scholar
  43. 43.
    Domermuth, C. H., M. H. Nielsen, E. A. Freundt, and A. Birch-Anderson: Ultra-structure of mycoplasma species. J. Bacteriol. 88, 727–744 (1964).PubMedGoogle Scholar
  44. 44.
    Eaton, M. D., G. Meiklejohn, and W. Herick: Studies on etiology of primary atypical pneumonia: I. Filtrable agent transmissable to cotton rats, hamsters, and chick embryos. J. exp. Med. 79, 649–668 (1944).PubMedCrossRefGoogle Scholar
  45. 45.
    Edwards, G. A., and J. Foen: Fine structure of pleuropneumonia-like organisms in pure culture and in infected tissue culture cells. J. Bacteriol. 79, 267–276 (1960).PubMedGoogle Scholar
  46. 46.
    Fleming, A.: On an remarkable bacteriolytic element found in tissues and secretions. Proc. Roy. Soc. 93, 306 (1922).CrossRefGoogle Scholar
  47. 47.
    Freundt, E. A.: The classification of the pleuropneumonia group of organisms Boreliomycetales. Intern. Bull. Bact. Nomencl. Taxon. 15, 67 (1955).Google Scholar
  48. 48.
    Freundt, E. A.: Morphology and classification of PPLO. Ann N Y Acad. Sci. 79, 312–325 (1960).PubMedCrossRefGoogle Scholar
  49. 49.
    Fouh, J., and Helle F.: A method for direct demonstration of pleuropneumonia-like organisms in cultured cells. Proc. Soc. Exper. Biol. Med. 117, 899–901 (1964).CrossRefGoogle Scholar
  50. 50.
    Fouh, J., and Helle F.: Chromosome changes in PPLO-infected FL-human amnion cell. Proc. Soc. exp. Biol. Med. 119, 233–238 (1965).CrossRefGoogle Scholar
  51. 51.
    Fouh, J., E Hahn, and H. Focx: Effects of pleuropneumonia-like organisms on cultured cells. Exp. Cell Research 39, 554–566 (1965).CrossRefGoogle Scholar
  52. 52.
    Girardi, A. J., V. V. Hamparian, N. L. Somerson, and L. Hayflick: Mycoplasma isolates from primary cell cultures and human diploid cell strains. Proc. Soc. exp. Biol. Med. 120, 760–771 (1965).PubMedCrossRefGoogle Scholar
  53. 53.
    Girardi, A. J., L. Hayflick, A. M. Lewis, and N. L. Somerson: Recovery of mycoplasmas in the study of human leucaemia and other malignancies. Nature 205, 188–189 (1965).PubMedCrossRefGoogle Scholar
  54. 54.
    Gori, G. B., and D. Young: A method for eradication of mycoplasma infections in cell cultures. Proc. Soc. exp. Biol. Med. 117, 918–921 (1964).PubMedCrossRefGoogle Scholar
  55. 55.
    Griffin, J. P., and J. E. Crawford: Mycoplasma pneumoniae in primary atypical pneumonia. J. Amer. med. Ass. 193, 1011–1016 (1965).CrossRefGoogle Scholar
  56. 56.
    Grist, N. R., and R. F. Fallon: Isolation of viruses from leukaemic patients. Brit. med. J. 2, 1263 (1964).PubMedCrossRefGoogle Scholar
  57. 57.
    Hartwich, J., and AND Müller: Zur Isolierung von Schweinemycoplasmen mit Hilfe des Eitestes and der Plattenkultur. Zbl. Bakter. I. Orig. 197, 532–543 (1965).Google Scholar
  58. 58.
    Hayflick, L., and H. Koprowsxi: Direct agar isolation of mycoplasmas from human leukaemic bone marrow. Nature 205, 713–714 (1965).PubMedCrossRefGoogle Scholar
  59. 59.
    Hearn, H. J., J. E. Officer, and A. Brown: Detection, elimination and prevention of contamination of cell cultures with pleuropneumonia-like organisms. J. Bacteriol. 78, 575–582 (1959).PubMedGoogle Scholar
  60. 60.
    Herderschee, D., A. C. Ruys, and G. R. Rhijn: A new oral mycoplasma isolated from the tonsils of two patients suffering from scarlatina. Antonie Leeuwenhoek 29, 157–162 (1963).Google Scholar
  61. 61.
    Herzberg, K., and W. Gross: Untersuchungen über Influenza. III. Mitt. Darstellung des filtrierbaren Pneumonieerregers durch den Mäuseversuch. Zbl. Bakter., I. Orig. 146, 129–139 (1941).Google Scholar
  62. 62.
    Holmgren, N. B., and W. E. Campbell: Tissue cell culture contamination in relation to bacterial pleuropneumonia-like organisms-L form conversion. J. Bacteriol. 79, 869–874 (1960).PubMedGoogle Scholar
  63. 63.
    Holmgren, N. B., and N. H. Smith: The effect of ultraviolett irradiation on PPLO in experimentally infected serum and on the imunitional quality of serum. Bacteriol. Proc. 1959, 58.Google Scholar
  64. 64.
    Inman, R., D. A. Woods, and G. Negroni: Electron microscopy of virus particles in cell cultures inoculated with passage fluid from human leukaemic bone marrow. Brit. med. J. 1, 927–929 (1964).CrossRefGoogle Scholar
  65. 65.
    Jansson, E. O., O. Wager, R. Stenström, E. Klemola, and P. Forsell: Studies on Eaton PPLO pneumonia. Brit. med. J. 1, 142–145 (1964).CrossRefGoogle Scholar
  66. 66.
    Jensen, K. E., L. B. Senterfit, R. M. Chanock, C. B. Smith, and R. H. Purcell: An inactivated mycoplasma pneumoniae Vaccine. J. Amer. med. Ass. 194, 248–252 (1965).CrossRefGoogle Scholar
  67. 67.
    Johnson, R. T., M. K. Coox, R. M. Chanock, and E. L. Buescher: Family outbreak of primary atypical pneumonia associated with Eaton agent. New Engl. J. Med. 262, 817–819 (1960).Google Scholar
  68. 68.
    Kim, K. S., W. R. Bibb, W. A. Clyde, and F. W. Denny: A new mycoplasma species from the human pharynx: Physical properties. Bacteriol. Proc., 1965, 56.Google Scholar
  69. 69.
    Klieneberger-Nobel, E.: Pleuropneumonia-like organisms (PPLO)-Mycoplasmataceae. London and New York: Acedemic Press 1962.Google Scholar
  70. 70.
    Klinge, K.: Über einen vom Chamäleon isolierten pleuropneumonieähnlichen Mikroorganismus (PPLO). Arch. Hyg. Bakteriol. 138, 332–344 (1954).PubMedGoogle Scholar
  71. 71.
    Köhler, W.: Die pleuropneumonie-ähnlichen Mikroorganismen (PPLO). Zbl. Bakter., II Ref. 175, 305–320 (1960).Google Scholar
  72. 72.
    Köhler, W.: Das Verhalten eines aviären und eines humanen PPLO-Stammes in virusinfizierten und ascitestumortragenden Mäusen. Z. Bakter., I. Orig. 185, 243–251 (1962).Google Scholar
  73. 73.
    Köhler, W.: Antibiotikaempfindlichkeit humaner PPLO-Stämme. Zbl. Bakter., I. Orig. 185, 355–366 (1962).Google Scholar
  74. 74.
    Kraemer, P. M.: Mycoplasma (PPLO) from covertly contaminated tissue cultures: Differences in Arginine degradation between strains. Proc. Soc. exp. Biol. Med. 117, 910–918 (1964).PubMedCrossRefGoogle Scholar
  75. 75.
    Krech, AND: Die Bedeutung der Mykoplasmen in der Humanmedizin. Schweiz. med. Wschr. 95, 1635–1640 (1965).Google Scholar
  76. 76.
    Krech, AND, and H. Modde: Untersuchungen über Häufigkeit und Bedeutung von Infektionen mit Mycoplasma pneumoniae. Dtsch. med. Wschr. 91, 1013–1015 (1966).CrossRefGoogle Scholar
  77. 77.
    Krücken, H., and H. Fabry: Pleuropneumonia-like organisms bei Morbus Reiter und verwandten Syndromen. Ärztl. Wschr. 10, 294 (1955).Google Scholar
  78. 78.
    Lecce, J. G.: Porcine polyserositis with arthritis isolation of a fastidious pleuropneumonialike organisms and Haemophilus influenzae-suis. Ann. N. Y. Acad. Sci. 79, 670–676 (1960).PubMedCrossRefGoogle Scholar
  79. 79.
    Lederberg, J., and S. Clair: Protoplasts and L-Type growth. of E. Coli. J. Bacteriol. 75, 143–147 (1958).Google Scholar
  80. 80.
    Lundblad, G., and E. Hultin: Human serum lysozyme (Muramidase). Scand. J. Clin. Laborat. Invest. 18, 201–208 (1966).CrossRefGoogle Scholar
  81. 81.
    Lwoff, A., and M. Lwoff: Studies on codehydrogenases: nature of growth factor „V“. Proc. Roy. Soc. (London) 122, 253–259 (1937).Google Scholar
  82. 82.
    Maliza, W F, M. F. Barile, and D. B. Riggs: Immunofluorescence of pleuropneumonialike organisms isolated from tissue cell culture. Nature 191, 190–191 (1961).CrossRefGoogle Scholar
  83. 83.
    Mooser, H.: Über die Mischinfektion der weißen Maus mit einem Stamm klassischen Fleckfiebers und dem Virus der infektiösen Ektromelie. Schweiz. Z. Path. Bakter. 6, 463–473 (1943).Google Scholar
  84. 84.
    Mooser, H., and N. Joos: Die Infektion der Maus mit menschlichen PPLO-Stämmen. Schweiz. Z. Path. Bakter. 15, 735–740 (1952).Google Scholar
  85. 85.
    Morton, H. E., P. F. Smith, and P. R. Lebermann: Symbiotic growth of pleuropneumonia-like organisms with bacterial colonies. Proc. Soc. exp. Biol. Med. 72, 328–330 (1949).PubMedCrossRefGoogle Scholar
  86. 86.
    Murphy, W. H., D. Furtado, and E. Plata: Possible association between leukaemia in children and virus-like agents. J. Amer. med. Assoc. 191, 110–115 (1965).CrossRefGoogle Scholar
  87. 87.
    Nasemann, TH., H. Röckl and O. Huber: Die pleuropneumonie-ähnlichen Organismen. Verhalten in der Eikultur und im Resistenzversuch. Klin Wschr. 32, 717–721 (1954).PubMedCrossRefGoogle Scholar
  88. 88.
    Negroni, G.: Isolations of viruses from leukaemic patients. Brit. med. J. 1, 927–929 (1964).PubMedCrossRefGoogle Scholar
  89. 89.
    Nocard, E., et E. R. Roux, and M.M. Borrel: Le microbe de la péripneumonie. Ann. Inst. Pasteur 12, 240 (1898).Google Scholar
  90. 90.
    Nowak, J.: Morphologie, nature et cycle evolutiv du microbe de la péripneumonie des bovidés. Ann. Inst. Pasteur 43, 1330 (1929).Google Scholar
  91. 91.
    Porter, G. H., A. J. Dalton, J. B. Moloney, and E. Z. Mitchell: Association of electron-dense particles with human acute leukaemia. J. Nat. Cancer Inst. 33, 547–556 (1964).PubMedGoogle Scholar
  92. 92.
    Prittwitz, C. H., and Gaffron, J.: Fehlerquellen bei der Begutachtung von Kulturen und mikroskopischen Präparaten pleuropneumonieähnlicher Organismen. Naturwiss. 42, 113–115 (1955).CrossRefGoogle Scholar
  93. 93.
    Randall, CH. C., Lanelle G Gafford, G. A. Gentry, and L. A. Lwason: Lability of host-cell-DNA in growing cell cultures due to mycoplasma. Science 149, 1098–1099 (1965).PubMedCrossRefGoogle Scholar
  94. 94.
    Robinson, L. B., R. H. Wichelhausen, and T. M. P. Brown: Sensitivity studies on human pleuropneumonia-like organisms. J. Lab. clin. Med. 39, 290–302 (1952).PubMedGoogle Scholar
  95. 95.
    Robinson, L. B., R. H. Wichelhausen, and B. Roizman: Contamination of human cell cultures by pleuropneumonia-like organisms. Science 124, 1147–1148 (1956).PubMedCrossRefGoogle Scholar
  96. 96.
    Röckl, H., TH. Nasemann and E. Stettwieser: Untersuchungen zur Pathogenität der Pleuropneumonieähnlichen Organismen im Urogenitaltrakt des Menschen mit besonderer Berücksichtigung der unspezifischen Urethritis. Hautarzt 5, 340–348 (1954).PubMedGoogle Scholar
  97. 97.
    Rothblat, G. H., and H. E. Morton: Detection and possible source of contaminatly pleuropneumonia-like organisms (PPLO) in culture of tissue cells. Proc. Soc. Expl. Biol. Med. 100, 87–90 (1959).CrossRefGoogle Scholar
  98. 98.
    Ruska, H., and K. Poppe: Elektronenmikroskopische Untersuchungen zur Morphologie der Seiffertschen Mikroorganismen und des Erregers der Lungenseuche des Rindes. Z. Hyg. 127, 201–215 (1947).CrossRefGoogle Scholar
  99. 99.
    Salton, M. R. J., and J. M. Ghuysen: Acetylhexosamine compounds anzymically released from Micrococcus lysodeicticus cell walls. Biochem. biophys. Acta. 45, 355 (1960).Google Scholar
  100. 100.
    Schimke, R. T., and M. F. Barile: Arginine metabolism in pleuropneumonia-like organisms isolated from mammalian cell culture. J. Bacteriol. 86, 195–206 (1963).PubMedGoogle Scholar
  101. 101.
    Schimke, R. T., and M. F. Barile: Arginine breakdown in mammalian cell culture contaminated with pleuropneumonia-like organisms (PPLO). Exper. Cell Research 30, 593–596 (1963).CrossRefGoogle Scholar
  102. 102.
    Schmidt, P. J., M. F. Barile, and M. H. Mcginniss: Mycoplasma (Pleuropneumonia-like organisms) and blood group I; associations with neoplastic disease. Nature 205, 371–372 (1965).PubMedCrossRefGoogle Scholar
  103. 103.
    Smith, W. E., J. Hillier, and ST. Mudd: Electron micrograph studies of two strains of pleuropneumonia-like (L) organisms of human derivation. J. Bacteriol. 56, 589–601 (1948).Google Scholar
  104. 104.
    Speck, J.: Vorkommen und Bedeutung von Mycoplasma laidlawi und Mycoplasma bovigenitalium im Genitaltrakt des Rindes. Monatsh. Tierhk. 14, 244–256 (1962).Google Scholar
  105. 105.
    Sterner, G., G. Heves, G. Tunevall, and S. Wolontis: An outbreak of mycoplasma pneumoniae in a home for children. Acta paed. (Uppsala), zit. nach 106.Google Scholar
  106. 106.
    Sterner, G., A. Svedmyr, G. Tunevall, and S. Wolontis: Infections with Eaton Agent in pneumonia. Acta Med. Scand. 178, 751–757 (1965).Google Scholar
  107. 107.
    Stolp, H., and M. P. Starr: Bacteriolysis. Ann. Rev. Microbiol. 19, 79–104 (1965).CrossRefGoogle Scholar
  108. 108.
    Taylor-Robinson, D., J. Canchola, H. Fox, and R. M. Chanock: A newly identified oral Mycoplasma (M. orale) and its relationship to other human mycoplasmas. Amer. J. Hyg. 80, 135–148 (1964).PubMedGoogle Scholar
  109. 109.
    Thacore, H., and H. P. Willett: Formation of spheroplasts of Mycobacterium tuberculosis by lysozyme treatment. Proc. Soc. exp. Biol. Med. 114, 43–47 (1963).PubMedCrossRefGoogle Scholar
  110. 110.
    Iterson, W., and A. C. Rums: On the nature of PPLO. II. Electron mycroscopy. Antonie van Leeuwenhoek. J. Microbiol. Serol. 26, 9–22 (1960b).Google Scholar
  111. 111.
    Welshimer, H. J.: The action of lysozyme on the cell wall and capsule of bacillus megaterium. J. Bacteriol. 66, 112–117 (1953).PubMedGoogle Scholar
  112. 112.
    Witzleb, W., M. Sprössig, G. Anger AND S. Heidler: Erkrankungen des Respirationstraktes durch Mycoplasma pneumoniae. Dtsch. med. Wschr. 91, 429–433 (1966).CrossRefGoogle Scholar
  113. 113.
    Zwick, W., E. Gildemeister, E. Haagen, O. Waldmann: Lungenseuche des Rindes, Pleuropneumonia bovum contagiosa. Hdb. d. Viruskrankheiten. 2. Bd. Jena: Gustav Fischer 1939.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1967

Authors and Affiliations

  • Friedrich J. Bassermann
    • 1
  1. 1.HeilstätteDonaustauf bei RegensburgDeutschland

Personalised recommendations